CIK 0001087294 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in TN · fiscal year ends 12/31
| FY2025 | FY2024 | FY2023 | |
|---|---|---|---|
| Revenue (USD) | 44.5 M | 39.6 M | 42.0 M |
| Net income (USD) | -2.8 M | -6.3 M | -5.6 M |
| Diluted EPS (USD/shares) | -0.19 | -0.44 | -0.38 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-09-11 | 8-K/A | 8-K/A items 5.07 | 2026-04-21 |
| 2026-08-28 | 8-K | 8-K items 7.01 | 2026-08-28 |
| 2026-08-07 | 10-Q | 10-Q | 2026-06-30 |
| 2026-08-04 | 8-K | 8-K items 2.02,9.01 | 2026-08-04 |
| 2026-07-13 | 8-K | 8-K items 8.01 | 2026-07-13 |
| 2026-07-01 | 8-K | FORM 8-K items 1.01,1.02,2.01,5.02,8.01,9.01 | 2026-06-29 |
| 2026-06-25 | 8-K | 8-K items 5.07 | 2026-06-24 |
| 2026-05-26 | DEFM14A | DEFM14A | |
| 2026-05-15 | PREM14A | PREM14A | 2026-05-15 |
| 2026-05-08 | 10-Q | 10-Q | 2026-03-31 |
| 2026-05-05 | 8-K | 8-K items 2.02,9.01 | 2026-05-05 |
| 2026-04-24 | 8-K | 8-K items 5.07 | 2026-04-21 |
| 2026-04-23 | DEFA14A | DEFA14A | |
| 2026-04-23 | 8-K | FORM 8-K items 1.01,7.01,8.01,9.01 | 2026-04-22 |
| 2026-03-20 | 4 | FORM 4 | 2026-03-18 |
| 2026-03-20 | 4 | FORM 4 | 2026-03-18 |
| 2026-03-20 | 4 | FORM 4 | 2026-03-18 |
| 2026-03-20 | 4 | FORM 4 | 2026-03-18 |
| 2026-03-20 | 4 | FORM 4 | 2026-03-18 |
| 2026-03-20 | 4 | FORM 4 | 2026-03-18 |
| 2026-03-20 | 4 | FORM 4 | 2026-03-18 |
| 2026-03-20 | 4 | FORM 4 | 2026-03-18 |
| 2026-03-20 | 4 | FORM 4 | 2026-03-18 |
| 2026-03-20 | 4 | FORM 4 | 2026-03-18 |
| 2026-03-18 | 4 | FORM 4 | 2026-03-16 |
Forms on file (last 1,000): 4 465, 8-K 227, 10-Q 52, SC 13G/A 33, CT ORDER 27, 3 23, SC 13G 22, CORRESP 21. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=CPIX (0.002 USD), /gw/filings/filings?ticker=CPIX&form=8-K, /gw/filings/facts?ticker=CPIX&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange